References
- Klose RJ , BirdAP. Genomic DNA methylation: the mark and its mediators. Trends Biochem. Sci.31(2) , 89–97 (2006).
- Kriaucionis S , HeintzN. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science324(5929) , 929–930 (2009).
- Tahiliani M , KohKP, ShenY et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324(5929) , 930–935 (2009).
- Ito S , ShenL, DaiQ et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333(6047) , 1300–1303 (2011).
- Nestor C , RuzovA, MeehanR, DunicanD. Enzymatic approaches and bisulfite sequencing cannot distinguish between 5-methylcytosine and 5-hydroxymethylcytosine in DNA. Biotechniques48(4) , 317–319 (2010).
- Gao F , XiaY, WangJ et al. Integrated detection of both 5-mC and 5-hmC by high-throughput tag sequencing technology highlights methylation reprogramming of bivalent genes during cellular differentiation. Epigenetics 8(4) , 421–430 (2013).
- Booth MJ , BrancoMR, FiczG et al. Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution. Science 336(6083) , 934–937 (2012).
- Yu M , HonGC, SzulwachKE et al. Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell 149(6) , 1368–1380 (2012).
- Deaton AM , BirdA. CpG islands and the regulation of transcription. Genes Dev.25(10) , 1010–1022 (2011).
- Wu T , GiovannucciE, WelgeJ, MallickP, TangWY, HoSM. Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis. Br. J. Cancer105(1) , 65–73 (2011).
- Hegi ME , DiserensAC, GorliaT et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N. Engl. J. Med.352(10) , 997–1003 (2005).
- Heyn H , EstellerM. DNA methylation profiling in the clinic: applications and challenges. Nat. Rev. Genet.13(10) , 679–692 (2012).
- Baylin SB , JonesPA. A decade of exploring the cancer epigenome – biological and translational implications. Nat. Rev. Cancer11(10) , 726–734 (2011).
- Kinney SM , ChinHG, VaisvilaR et al. Tissue-specific distribution and dynamic changes of 5-hydroxymethylcytosine in mammalian genomes. J. Biol. Chem. 286(28) , 24685–24693 (2011).
- Jin SG , JiangY, QiuR et al. 5-hydroxymethylcytosine is strongly depleted in human cancers but its levels do not correlate with IDH1 mutations. Cancer Res. 71(24) , 7360–7365 (2011).
- Hitchins MP , RapkinsRW, KwokCT et al. Dominantly inherited constitutional epigenetic silencing of MLH1 in a cancer-affected family is linked to a single nucleotide variant within the 5´UTR. Cancer Cell 20(2) , 200–213 (2011).
- Teng IW , HouPC, LeeKD et al. Targeted methylation of two tumor suppressor genes is sufficient to transform mesenchymal stem cells into cancer stem/initiating cells. Cancer Res. 71(13) , 4653–4663 (2011).
- Rivenbark AG , StolzenburgS, BeltranAS et al. Epigenetic reprogramming of cancer cells via targeted DNA methylation. Epigenetics 7(4) , 350–360 (2012).
- Gregory DJ , MikhaylovaL, FedulovAV. Selective DNA demethylation by fusion of TDG with a sequence-specific DNA-binding domain. Epigenetics7(4) , 344–349 (2012).